- Home
- PBYI vs LWAY Comparison
PBYI vs LWAY Comparison
Compare PBYI & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBYI | LWAY |
|---|---|---|
| Founded | 2010 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 413.3M | 481.4M |
| IPO Year | 2011 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PBYI | LWAY |
|---|---|---|
| Price | $9.41 | $25.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $34.50 |
| AVG Volume (30 Days) | ★ 304.1K | 161.6K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 48.33 |
| EPS | 0.08 | ★ 0.31 |
| Revenue | $27,685,000.00 | ★ $103,350,000.00 |
| Revenue This Year | N/A | $16.64 |
| Revenue Next Year | N/A | $17.28 |
| P/E Ratio | $121.13 | ★ $84.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.30 | $17.31 |
| 52 Week High | $9.74 | $34.20 |
Technical Indicators
Market Signals| Indicator | PBYI | LWAY |
|---|---|---|
| Relative Strength Index (RSI) | 61.55 | 39.55 |
| Support Level | $7.56 | $22.86 |
| Resistance Level | N/A | $27.76 |
| Average True Range (ATR) | 0.36 | 0.90 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 78.01 | 40.76 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About LWAY Lifeway Foods Inc.
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.